Dedicated to the development of a medical device that will reduce the chance of cesarean section by an estimated 20% for those with failure to progress in labor and prevent injury to sensitive maternal tissues. Funding goals have been set to cover the cost needed to cover phases 1 thru 5 in the development process. The device has been patented and VitaTek has been selected to develop the device so it can be used by laboring women around the world.
Preventing The Primary Section